These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6830659)

  • 1. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
    Manz M; Steinbeck G; Nitsch J; Lüderitz B
    Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric use of mexiletine and disopyramide.
    Holt DW; Walsh AC; Curry PV; Tynan M
    Br Med J; 1979 Dec; 2(6203):1476-7. PubMed ID: 526816
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
    Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

  • 7. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine].
    Ricciardelli B; Volpe M; De Luca N; D'Ascia C; Bonaduce D; Trimarco B; Rengo F; Condorelli M
    Boll Soc Ital Cardiol; 1981; 26(2):139-44. PubMed ID: 7337769
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
    Lüderitz B; Manz M; Steinbeck G
    Dtsch Med Wochenschr; 1983 Nov; 108(44):1663-7. PubMed ID: 6414795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    Lerman BB; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new antiarrhythmia drugs disopyramide and mexiletine].
    Härtel GU
    Duodecim; 1980; 96(5):420-9. PubMed ID: 7449686
    [No Abstract]   [Full Text] [Related]  

  • 14. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hirosawa K
    Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine for treatment of sustained recurrent ventricular tachycardia.
    Santinelli V; Chiariello M; Stanislao M; Condorelli M
    Int J Cardiol; 1983; 2(3-4):443-5. PubMed ID: 6840912
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
    Camm J; Ward D; Washington HG; Spurrell RA
    Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mexiletine in the treatment of lidocaine-resistant ventricular tachycardia. Preliminary results].
    Santinelli V; Chiariello M; Stanislao M; Turco P; Clarizia M; Condorelli M
    G Ital Cardiol; 1982; 12(6):457-9. PubMed ID: 7160572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
    Belhassen B; Pines A; Laniado S
    Chest; 1989 Apr; 95(4):918-20. PubMed ID: 2924626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.